BOSTON (AP) _ Ziopharm Oncology Inc. (ZIOP) on Monday reported a loss of $12.7 million in its third quarter.
On a per-share basis, the Boston-based company said it had a loss of 13 cents.
The results met Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was also for a loss of 13 cents per share.
The drug developer posted revenue of $1.6 million in the period, also matching Street forecasts.
In the final minutes of trading on Monday, the company's shares hit $4.67. A year ago, they were trading at $5.48.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ZIOP at https://www.zacks.com/ap/ZIOP